Ishida H, Ohta Y, Tsukada Y, Kiso M, Hasegawa A
Department of Applied Bioorganic Chemistry, Gifu University, Japan.
Carbohydr Res. 1993 Aug 17;246:75-88. doi: 10.1016/0008-6215(93)84025-2.
A stereocontrolled, facile total synthesis of ganglioside GD3 is described as an example of a proposed systematic approach to the preparation of gangliosides containing an alpha-sialyl-(2-->8)-sialic acid unit alpha-glycosidically linked to O-3 of a D-galactose residue in their oligosaccharide chains. Glycosylation of 2-(trimethylsilyl)ethyl 6-O-benzoyl-, 3-O-benzoyl-, or 3-O-benzyl-beta-D-galactopyrano-sides, or 2-(trimethylsilyl)ethyl 2,3,6,2',6'-penta-O-benzyl-beta-lactoside (7), with methyl [phenyl 5- acetamido-8-O-(5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D- glycero-alpha-D-galacto-2-nonulopyranosylono-1',9 lactone)- 4,7-di-O-acetyl-3,5-dideoxy-2-thio-D-glycero-D-galacto-2-nonulopyrano sid] onate (3), using N-iodosuccinimide-trifluoromethanesulfonic acid as a promoter, gave the corresponding alpha glycosides 8 (32%), 13 (33%), 14 (48%), and 17 (31%), respectively. The glycosyl donor 3 was prepared from O-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranosy lonic acid)-(2-->8)-5-acetamido-3,5- dideoxy-D-glycero-D-galacto-2-nonulopyranosonic acid by treatment with Amberlite IR-120 (H+) in methanol, O-acetylation, and subsequent replacement of the anomeric acetoxy group with phenylthio. Compound 8 was converted into the methyl beta-thioglycoside via O-benzoylation, replacement of the 2-(trimethylsilyl)ethyl group by acetyl, and introduction of the methylthio group by reaction with methylthiotrimethylsilane. Compound 17 was converted, via O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group, and reaction with trichloroacetonitrile, into the alpha-trichloroacetimidate, which was coupled with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol to give the beta-glycoside. This glycoside was easily transformed, via selective reduction of the azido group, condensation with octadecanoic acid, O-deacylation, and hydrolysis of the methyl ester and lactone functions, into ganglioside GD3.
本文描述了神经节苷脂GD3的立体控制、简便的全合成方法,以此作为一种拟议的系统方法的示例,该方法用于制备在其寡糖链中含有α-唾液酸基-(2→8)-唾液酸单元且以α-糖苷键连接至D-半乳糖残基O-3位的神经节苷脂。使用N-碘代琥珀酰亚胺-三氟甲磺酸作为促进剂,使2-(三甲基甲硅烷基)乙基6-O-苯甲酰基-、3-O-苯甲酰基-或3-O-苄基-β-D-吡喃半乳糖苷,或2-(三甲基甲硅烷基)乙基2,3,6,2',6'-五-O-苄基-β-乳糖苷(7)与甲基[苯基5-乙酰氨基-8-O-(5-乙酰氨基-4,7,8,9-四-O-乙酰基-3,5-二脱氧-D-甘油-α-D-半乳糖-2-壬吡喃糖醛酸)-4,7-二-O-乙酰基-3,5-二脱氧-2-硫代-D-甘油-D-半乳糖-2-壬吡喃糖苷]酸酯(3)进行糖基化反应,分别得到相应的α-糖苷8(32%)、13(33%)、14(48%)和17(31%)。糖基供体3由O-(5-乙酰氨基-3,5-二脱氧-D-甘油-α-D-半乳糖-2-壬吡喃糖醛酸)-(2→8)-5-乙酰氨基-3,5-二脱氧-D-甘油-D-半乳糖-2-壬吡喃糖醛酸经在甲醇中用Amberlite IR-120(H+)处理、O-乙酰化,随后用苯硫基取代异头乙酰氧基制得。化合物8经O-苯甲酰化、用乙酰基取代2-(三甲基甲硅烷基)乙基基团,并与甲硫基三甲基硅烷反应引入甲硫基,转化为甲基β-硫代糖苷。化合物17经O-乙酰化、选择性除去2-(三甲基甲硅烷基)乙基基团,并与三氯乙腈反应,转化为α-三氯乙亚胺酯,其与(2S,3R,4E)-2-叠氮基-3-O-苯甲酰基-4-十八碳烯-1,3-二醇偶联得到β-糖苷。该糖苷经叠氮基的选择性还原、与十八烷酸缩合、O-脱酰基以及甲酯和内酯官能团的水解,可轻松转化为神经节苷脂GD3。